Find out why you should join, what you will gain and how to apply to become a member of ESMO
See the full list of benefits that ESMO members enjoy including access to OncologyPRO, subscription to Annals of Oncology and reduced meeting registration fees.
A unique networking resource for ESMO members wishing to contact one another.
We have a network of National and Regional Representatives who act as ambassadors of ESMO’s mission in their respective country or region
The member panel gives feedback on ESMO products and services through the completion of regular online surveys. Would you like to contribute?
Follicular Lymphoma – the latest 2014 guidelines update is now online!
Download the new version of our App with the latest Pocket Guidelines for professionals and Guides for Patients
ESMO practice tools can now be found on OncologyPRO
Manuscripts from ESMO Consensus Conferences can now be found on OncologyPRO
ESMO Spotlights can now be found on OncologyPRO
Find out all you need to know about the
#ESMO14 Congress taking place on 26-30 Sep 2014 in Madrid, Spain
The 6th European Multidisciplinary Meeting on Urological Cancers will be held in Lisbon, Portugal. 13-16 November 2014
Join us in Geneva, Switzerland. 21-22 November 2014
Join us in Barcelona, Spain for Signalling Pathways 2015. 13-14 March 2015
Save the date for ELCC 2015. Geneva, Switzerland; 15-18 April 2015
Save the date for the IMPAKT 2015 breast cancer conference: 7-9 May 2015
The first ESMO Asia congress wil take place in Singapore, 18-21 December 2015
ESMO preceptorships and courses are led by experts and specialists in a particular field and offer close interaction with the faculty to maximise the learning outcomes
View the complete list of ESMO oncology conferences including partnership, labelled and supported meetings.
Access information and reports from past ESMO events
Addressing the daily needs of ESMO young oncologists
Invest in your future and the future of cancer care. Learn more about our Oncology Fellowship Programme.
The latest oncology jobs can be found here, including information on how to post a job.
The winners of the 2014 ESMO Awards, to be presented during the congress in Madrid, will be announced in August
The Recommendations are a set of guidelines with for clinical training in medical oncology. The 2010 update is now available in Portuguese.
ESMO fosters the advancement of cancer research by supporting clinical trials workshops to inspire young oncologists from different disciplines across the globe to become the next generation of active researchers.
ESMO members – there are still a few places left to take the ESMO exam at the main session in Madrid
If you’ve already sat the ESMO exam, then take a look at our CME opportunities.
Discover the results of the ESMO Survey on the challenges of female oncologists carried out in August 2013.
Guides for Patients are designed to assist patients and their relatives. Available now on mobile app in 4 languages!
Now available in Greek, our Guide for Patients with Advanced Cancer is designed for patients, their family members and oncologists.
The ESMO Designated Centres of Integrated Oncology and Palliative Care accreditation programme recognises cancer centres which provide comprehensive services in supportive and palliative care as part of their routine care.
Read the reports from the ESMO/EAPC opioid survey and the oncologist/patient communication survey.
An integral part of our mission is to keep patients informed about the latest advances in cancer care.
The ESMO Patient Track encourages communication between patients, families, oncologists and healthcare professionals.
Medical oncology is included among the medical specialities covered by the European Commission Directive 2005/36/EC.
ESMO’s political initiatives aim to promote the profession of medical oncology and keep cancer policy high on the European healthcare agenda.
ESMO position statements and recommendations can be downloaded here.
Rare Cancers Europe is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda.
The objective of this ESMO-led study is to provide European health authorities with data on the availability of licensed anti-neoplastic medicines across Europe
ESMO has endorsed the 'Prague Charter: Relieving suffering' set up by the European Association for Palliative Care (EAPC) & other organisations
ESMO seeks to eradicate cancer at its earliest stages through effective cancer prevention awareness and advocacy campaigns.
News from the ESMO Policy section